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ABSTRACT
Objective: To determine the factors influencing parental acceptance of the HPV vaccine 
for their pre-pubertal (age group 9-14 years) daughters. 
Design: Cross sectional study.
Setting: Four primary schools within Langata constituency in Nairobi County in June 
2010. 
Subject: Girls in Standard five to eight were selected for the study. A self explanatory 
one page questionnaire was given out to take to their mothers/guardian and returned in 
one week. Fifty mothers were then randomly selected from the returned questionnaires 
and an in depth telephone interview was conducted. The data entry and coding was 
done and analysed using SPSS version 15.
Results: In this study 68% of parents/guardians accepted that vaccination should be 
done but only 58% agreed that their daughters should be vaccinated, majority of the 
respondents were females, (women 82% and men 18 %). This observed difference 
across the genders was not statistically significant p=0.078. The level of education of 
the respondent (nil 2.7%, primary 6.6%, college /university 47.7% secondary 45.7%) 
the observed difference across the educational levels of agreeing to vaccination was 
not statistically significant p=0.898. The knowledge/awareness on cervical cancer and 
its relationship to HPV infection correlated with the level of education was found to 
have been statistically significant. The parents recommended age of vaccination was 
11-13 year (58%). Parent/guardians suggested age of vaccination and HPV vaccine 
acceptance was significant correlated with the vaccination acceptance by the parents 
p=0.009.   This study has shown that the recommended age of vaccination by parents 
is 11-13years age group which was similar to findings done in many countries.
Conclusion: There was poor knowledge on the relationship between HPV infection 
and cervical cancer. The acceptable age of vaccine administration was 11-13 years.
INTRODUCTION
The burden of the disease of cancer of the cervix is 
increasing at an alarming rate worldwide. In the 
sub Saharan countries it is now the leading cause of 
cancer related deaths among women. This trend if 
not checked will lead to increased strain in the health 
sector resources (2). Cervical cancer deaths are now 
estimated at 1350 annually in Kenya and the figure 
may be much higher since these are only hospital 
based data and many are dying in the rural areas 
whose cause of death is never documented.  Use of 
the Pap smear has significantly reduced the incidence 
and mortality of cervical cancer in women who have 
regular screening and follow-up in the developed 
countries (5). However, the Pap smear test has been 
inadequate in universally preventing cervical cancer. 
Pap smear sensitivity is poor, ranging from 50 to 74%, 
depending on the methodology (6).
 In addition to other known cervical preventive 
interventions like Pap smear, visual inspection with 
acetic acid (VIA), visual inspection with Lugols 
iodine (VILI) and Colposcopy. There is now hope of 
reducing the incidence of cervical cancer by the use 
of vaccines (8,12). Normally vaccines are generally 
given for two reasons. One is to provide a public 
health benefit and the other is to provide benefit to 
specific individuals. The public health benefits of 
vaccination are obvious to everyone. The decision to 
include a specific vaccine in a national vaccination 
programme and the target population for vaccination 
is generally made by government advisory panels 
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following technical advice. 
 It has now been conclusively shown that the 
Human papilloma virus (HPV) types 16 and 18, have 
a causal relationship in the development of invasive 
cervical cancer in 70-80% of patients who develop the 
disease. The cervical changes usually start as dysplasia 
and may take up to fifteen years to invasion (12). 
 HPV vaccine has been with us in the country 
for more than five years now. Yet there is limited 
information on the parental acceptability of the 
vaccine use in this country. This study addresses 
this gap. Some of the cervical cancer prevention 
strategies have involved the advocacy on Pap smear 
as a screening tool, but this has failed in many ways 
since very few are able to access it and also it need 
trained personnel to realise it.  This then would 
make the vaccination programme if acceptable more 
effective. 
 This study sought to answer the following 
question: What would be the rates of HPV vaccine 
acceptance, by the parents/guardians and the age at 
which parents/guardians would accept to have the 
HPV vaccine administered to their daughters? 
 
MATERIALS AND METHODS
Study design: This was a cross sectional study to determine 
the parental acceptance of the HPV vaccine.
Study population: Primary schools girls between age 9 
to 14 years were chosen since they were considered as 
a good entry point into the community and since they 
are the likely target in the vaccine introduction in the 
country.  It gives an opportunity for the community 
to participate in the decision making process.
Sampling method: Structured questionnaires were 
sent to the mothers (parent/guardian) through 
their daughters in standard five to eight classes. 
The questionnaires were given to the girls in their 
respective schools after the Principal investigator 
had explained to them about the study. They had 
the opportunity to ask questions about the study 
and cervical cancer in general. All the questionnaires 
were distributed to the pupils by their class teachers 
at the end of the class in the afternoon before leaving 
school for home, and asked to take to their mothers/
guardians to fill in the questionnaires and return 
them within one week. There was no coercion or 
inducement given to the school girls by the Head 
teacher, Class teacher or the principal investigator. 
The Head teacher received the filled questionnaires 
on return, for collection by the principal investigator. 
Limitation of the study was that since the study was 
involving a relatively low socio-economic group the 
understanding of the study may have been limited. 
Sample size: The p-value was taken as 70% from the 
study done in the United Kingdom, which had an 
acceptance rate of 70% (15). this gave a calculated 
sample size of 332. 
Study site: The study was carried out in four mid and 
lower levels Nairobi city council primary schools 
located in the Langata area of Nairobi County. The 
schools had five streams each with approximately 50 
pupils half of whom were girls, and this made the 
sample size achievable. The choice of the four schools 
was determined by the large pupil population whose 
parents/guardians were from both the middle and 
low socio-economic levels. A convenience sampling 
was used till the sample size was attained. 
Data management: Data entry and coding was carried 
out after data cleaning, a trained biostatistician 
supervised the process. The data analysis was 
done using Statistical Package for Social Science 
no 15 (SPSS). The accepted age of vaccination 
was determined. The correlation between sex and 
acceptance of HPV vaccine administration was also 
determined.  
Ethical considerations: This study was approved 
by the Kenyatta National hospital/University of 
Nairobi Research and ethics committee, it was a 
questionnaire based study which targeted the parents 
and guardians of the girls using the girl pupils as the 
link. This approach has been used before in other 
studies (14). The parents /guardians were able too 
fill in the questionnaires without contact with the 
research team.
RESULTS
Profile of participants: Questionnaires were received 
from 332 participants. Data from the demographic 
part of the questionnaires yielded the information 
about respondents’ demographic profile variables 
shown on Table 1. This personal information includes 
respondent’s age, gender and education.   Three 
hundred and thirty two (n=332) respondents returned 
their questionnaires. However, as  Table 1 shows, all 
demographic questions were not answered by all the 
respondents; therefore frequencies indicated in Table 
1 were often less than the total number (N=332) of 
respondents. 
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Table 1 
Demographic profile of respondents
Demographic of Subjects N Percentage
Respondent 
          Father 51 15.8
          Not indicated 40 12.4
          Guardian 13 4.0
          Mother 231 71.8
  
 Total 322 100
Gender  
          Female 231 81.9
          Male  51 18.1
 Total 282 100
Guardian’s Education  
          College/University 123 47.7
          Primary 17 6.6
          Secondary 118 45.7
          Total 258 100
Daughter’s Age  
          <10 38 11.8
          11-15 282 87.3
          >15 3 0.9
          Total 322 100
Guardian’s Age  
          <20 4 1.3
          21-30 30 9.9
          31-40 172 57
          41-50 82 27.2
          >50 14 4.6
          Total 302 100
 Majority of the respondents by gender 82% were 
females. When all had attained a primary level of 
education and above. Eighty eight percent of the girls 
were in the 11-15 year age bracket which would be 
expected in the primary school picked for the study. 
There were 12.4% of the respondents who did not 
indicate their gender on the questionnaires and it 
was not possible to determine who they were since 
the questionnaires were anonymous with no contact 
with the respondents. 
 Majority of the respondents (47.7%) had College/
University education, 45.7% of them had only secondary 
education, and 6.6% had University education and while 
only 2.7% hand no education at all. 
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A higher percentage of female respondents (71%) 
than males (68.9%) reported they would agree to 
cervical cancer vaccination. However, this differences 























Acceptance to HPV vaccination 
Percentage of those who would agree to cervical 
cancer vaccination by Gender of Respondent
MALE
cervical cancer vaccination was not statistically 
significant across gender based on a chi-square test 
of independence (Chi2 (1) =.11, p=.737).
 
Figure 4
Parents’ Suggested Age for HPV Vaccination
56.8% of the respondents recommended age of vaccination was in the age group of 11-13 years, 18% 
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Figure 5
Parents suggested age of HPV vaccination by gender
Parents’ Suggested of Age of HV Vaccination By Parent Gender
Both the male and female respondents agreed to the age group of 11-13 to have been the acceptable 
age of vaccination. 
Table 2
Various correlates and HPV vaccine acceptance
Associations between Various correlates and Acceptance of Vaccine
  Accept HVP Vaccine  p-
 Total No yes  value 
Level of education    
               Primary 17 8(47.1) 9(52.9) 
               Secondary 118 39(33.1) 79(66.9) 0.418
               College/University 123 48(39.0) 75(61) 
Knowledge of Cancer of Cervix,    
    Ever heard of cancer of the cervix    
               No 71 35(25.7) 36(18.4) 
               yes 261 101(74.3) 160(81.6) 0.107
     Do you know of what may cause cancer of cervix    
               No 237 105(77.2) 132(67.3) 
               yes 95 31(22.8) 64(32.7) 0.051
     Do you know what a pap test is used for    
               No 173 69(50.7) 104(53.1) 
               yes 159 67(49.3) 92(46.9) 0.677
     Have you heard of human papilloma virus(HPV)    
               No 246 97(71.3) 149(76) 
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     Knowledge of HPV relationship with cervical cancer    
               No 285 111(81.6) 174(88.8) 
               yes 47 25(18.4) 22(11.2) 0.066
Gender of respondent    
               Female 232 67(80.7) 164((82.4) 
               Male 51 16(19.3) 35(17.6) 0.737
Suggested Age of Vaccination    
               <=10y 36 0(0) 36(20.7) 
               11-13y 109 4(22.2) 105(60.3) 
               14-17y 34 7(38.9) 27(15.5) 0.001
               18-20y 11 6(33.3) 5(2.9) 
               >20y 2 1(5.6) 1(.57) 
The suggested age of vaccination was found to have been a significant correlation with the HPV 
vaccine use p=0.001.  The gender p=0.737, knowledge of HPV p=0.066, level of education p=0.418 
were not statistically significant. 
DISCUSSION
One of the recommendations in achieving primary 
prevention is the use of HPV vaccine. The 
recommendation is to vaccinate pre-pubertal young 
girls, where the parental consent is mandatory. In this 
study the parental acceptance for vaccination was 
68% and those who indicated that they agreed to have 
their daughter vaccinated was only 59%. This finding 
is at variance with the finding of Becker et al who in 
their study on the HPV vaccine acceptance among 
Kenyan woman reported acceptance  95% (23). In their 
study the mothers were being interviewed directly 
while in this study the questionnaire was filled by 
the responded without contact with the investigator, 
therefore, this may be more objective than the direct 
interview. In Manchester, United Kingdom, the 
acceptance was at 70% while in the Netherland the 
acceptance was at 88% (8,9,15,16). The low acceptance 
rate finding (59%) in this study could be explained 
by the study population who were from the low 
income setting in the Nairobi County and had low 
awareness of HPV infection(25.9%) and only 14.2% 
knew of the relationship between HPV infection and 
the development of cervical cancer. 
 Studies done on acceptance of HPV vaccination 
in many countries have yielded a universal verdict 
that it is acceptable. In a study carried out in Canada 
to asses, among other factors, the target groups for 
vaccination (N-157) the findings were that both the 
boys and girls should be included in the vaccination 
programme (20). The study only looked at the parental 
acceptance of the vaccination of girls. 
 It is known that the cheapest way to screen for 
cancer of the cervix is to have routine regular pap 
smears. This study looked into the awarenesss of pap 
smear as a screening procedure for cervical cancer 
almost an equal number indicated either knowledge 
of (48%) or none (52%) on the importance of pap 
smear in cervical cancer screening. The knowledge of 
pap smear use, gender of the respondent, age of the 
respondent, and level of education and HPV vaccine 
acceptance was found not to have been statistically 
significant. The suggested age of vaccination was 
found to have been statistically significant p=0.001
 The prevention of HPV infection is achievable 
if vaccination is carried out early before sexual 
debut, and this is the reasoning behind the 
recommendation of early vaccination. In many 
countries the recommended age is between 9-12 years 
of age. In this study 57% of the parents/guardians 
recommended age of vaccination against HPV was 
in the age group of 11-13 years. This study found that 
even in a low socio-economic setting the awareness 
of HPV vaccination for protection against HPV was 
high (71%) female and 69% males. And of interest the 
acceptance of vaccination against HPV was higher 
in the males (72.5%) against (59.3%) of the females. 
It would be of interest to carry out further studies to 
determine the reasons behind this finding. 
 The level of education would be expected 
to be related to increased knowledge on cervical 
cancer. In this study the findings were that there was 
a corresponding increase in the awareness of cancer 
of the cervix by the level of education (Primary-
64.7%,Secondary-76.3%, College/University-88.6 %). 
These findings were statistically significant (chi2) 9.41 
p=0.009. This is the expected trend since education 
should relate to more awareness.
 Many studies looking at the parental attitudes 
have now been carried out in many countries 
especially in the countries where the programme 
has been accepted. In this study looking at Parental 
attitudes and information needs in an adolescent HPV 
vaccination programme in Manchester UK, smith et al 
found that 20% of the parents were not satisfied with 
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the programme although the state had introduced a 
vaccination programme in the age groups of 12-13 
years (21).
 In this study some of the parental responses 
were very interesting, some believed that the 
daughters were too young and that vaccination would 
bring in serious side effects.  Many of those interviewed 
reported that they needed more information on the 
vaccine. Some believed that God will protect their 
daughters from the infection. While some of the 
respondents said they could not trust doctors with 
their daughters and, therefore, did not see the need 
for vaccination. Few reported that they believed 
the vaccination may lead to promiscuity. Allen et 
al in their study looking into factors influencing 
parental acceptance of vaccine, found that suboptimal 
information is a key factor influencing the uptake and 
any intervention must address the parental concerns 
(22). This study showed that there is this information 
gap.
 This study has demonstrated that while 
HPV infection vaccine uptake (68%) is acceptable 
only 59% would agree to actually have the vaccine 
administered to their prepubertal and teenage 
daughters. Most parents reported the need for more 
information, which is the trend shown in many 
studies done world-wide. The use of schools as an 
entry point to the community should be encouraged 
and this can be achieved by addressing the Parents 
Teachers Association meetings and disseminating the 
findings of this study. Hopefully it would influence 
the parental acceptance of vaccine uptake. 
In conclusion, there was poor knowledge on the 
relationship between HPV infection and cervical 
cancer. The acceptable age of vaccine administration 
was the 11-13-year age bracket. This was found 
to have been significantly related to HPV vaccine 
acceptance, the level of education had an influence 
on the knowledge of HPV infection and cervical 
cancer. More information on HPV vaccine should be 
disseminated to parents especially through the schools 
so as to bridge the knowledge gap which is evident 
among the parents.
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